Qiagen NV
NYSE:QGEN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
39.23
47.06
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Qiagen NV
Wall Street
Price Targets
QGEN Price Targets Summary
Qiagen NV
According to Wall Street analysts, the average 1-year price target for
QGEN
is 51.94 USD
with a low forecast of 45.45 USD and a high forecast of 63 USD.
QGEN Last Price Targets
Qiagen NV
The latest public price target was made on Oct 17, 2024 by
Shubhangi Gupt
from
HSBC
,
who expects
QGEN
stock to
rise by 9%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Shubhangi Gupt
HSBC
|
49
USD
Upside 9% |
2 months ago
Oct 17, 2024
|
Qiagen downgraded to Hold from Buy at HSBC
TheFly
|
Doug Schenkel
Wolfe Research
|
50
USD
Upside 12% |
5 months ago
Jun 27, 2024
|
Wolfe Research Upgrades Qiagen NV (QGEN) to Outperform
StreetInsider
|
John Sourbeer
UBS
|
46
USD
Upside 3% |
6 months ago
Jun 18, 2024
|
Qiagen NV (QGEN) PT Raised to $46 at UBS
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is QGEN's stock price target?
Price Target
51.94
USD
According to Wall Street analysts, the average 1-year price target for
QGEN
is 51.94 USD
with a low forecast of 45.45 USD and a high forecast of 63 USD.
What is Qiagen NV's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Qiagen NV's revenue is
5%.
The projected
CAGR
for the next 4 years is
7%.
What is Qiagen NV's Operating Income forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
Qiagen NV's operating income is
12%.
The projected
CAGR
for the next 4 years is
16%.
What is Qiagen NV's Net Income forecast?
Projected CAGR
17%
For the last 8 years the
compound annual growth rate for
Qiagen NV's net income is
13%.
The projected
CAGR
for the next 4 years is
17%.
You don't have any saved screeners yet
